OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a ...

BETHLEHEM, Pa. - The product that put OraSure on the map more than two decades ago is expanding its reach. On Tuesday the ...

People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral ...

BETHLEHEM, Pa.- OraSure Technologies, the Bethlehem-based medical device maker, is cutting jobs. A company spokesperson told ...

TORONTO — ...

OraSure Technologies said Friday that it is reducing a “mid-single digits percent” of its workforce, including 10 at its south Bethlehem headquarters. A spokesperson for the diagnostic test kit and ...

OraQuick HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick HIV ...

Expansion of the OraQuick® HIV Self-Test to individuals aged 14 and older increases access to vital HIV testing for adolescents, addressing a significant public health need. The approval aligns with ...

OraSure Technologies Inc. is a health and wellness company specializing in "easy to use" diagnostic and specimen collection products. OraSure has a strong balance sheet and is trading below its net ...

BETHLEHEM, Pa., Dec. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (OSUR), a global leader in the fight against HIV, will ring the closing bell for the Nasdaq Stock Market this afternoon in ...

OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at-home tests for sexually transmitted infections (STIs), aiming to expand ...